SECsGRUES: Plasma Concentration of Somatostatin and Endocannabinoids After GA and RA in Upper Extremity Trauma Surgery

Sponsor
University of Pecs (Other)
Overall Status
Recruiting
CT.gov ID
NCT04040738
Collaborator
(none)
100
1
2
26.2
3.8

Study Details

Study Description

Brief Summary

The application of RA can decrease the central sensitization and chronic pain after trauma surgery. The plasma concentrations of somatostatin and fatty acid amides were not studied up to this time in this kind of settings, so investigators believe that this is the first work that shows how upper extremity nerve blockade changes the plasma concentration of somatostatin and fatty acid amides in upper limb surgery in trauma patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Upper extremity surgery under general anaesthesia
  • Procedure: Upper extremity surgery under regional anaesthesia
N/A

Detailed Description

Total of 100 American Society of Anesthesiologist (ASA) I-III, adult patients scheduled to elective or emergency trauma surgery of hand/forearm or shoulder are planned to be randomly allocated to general anaesthesia (GA) or ultrasound-guided (UG) brachial plexus block (BPB) group, in this randomized-prospective study after approval by the University Research Ethics Board, Pécs University Medical School, Hungary. All of the patients will receive detailed information about the planned BPB or GA techniques and surgeries, then written informed consents will be obtained. Study participants are planned to be assigned randomly into 4 groups (Shoulder GA; Shoulder RA; Hand/forearm GA; Hand/forearm RA).

Standardized UG Axillary-supraclavicular (AX-SC) approach to the BP is planned to be performed under sterile conditions, or standardized GA with propofol IV, fentanyl IV, and 1 MAC (minimal alveolar concentration) sevoflurane, by experienced anesthesiologists.

Blood samples will be taken at 0-time point (straight before the administration of BP injection or the induction of GA) and straight after the surgery. The collected serum samples are stored at -70 °C for a maximum of two weeks prior to analysis. Qualitative and quantitative determination of endocannabinoids and corticosteroids is performed by supercritical fluid chromatography coupled with tandem mass spectrometry after salting-out assisted liquid-liquid microextraction. For somatostatin measurement, the samples are immediately supplemented with aprotinin (20µl/ml blood sample; Gordox 10 KIU/ml (Kallikrein Inhibitor Unit/ml), Richter Gedeon Budapest, Hungary) and transported for centrifugation on ice. The pellet is discarded, and the plasma is stored at -80⁰C until further processing. The somatostatin concentration of the plasma sample is determined with both ELISA (CEA592Hu, Cloud-Clone Corp., Wuhan, PRC) and radioimmunoassay. The results are collected and analyzed.

Demographic data, vital parameters, and verbal numeric rate of pain intensity are collected prior to and after surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Study participants n=25 in the S-GA, n=25 in the S-RA, n=25 in the H-GA, and n=25 in the H-RA Groups.Study participants n=25 in the S-GA, n=25 in the S-RA, n=25 in the H-GA, and n=25 in the H-RA Groups.
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
The labour analyst, the investigator, the statistician is unaware of group allocation.
Primary Purpose:
Basic Science
Official Title:
Comparative Measurement of the Concentration of Blood Somatostatin and Fatty Amid Acids in Upper Extremity Trauma Surgery Under General and Regional Anesthesia
Actual Study Start Date :
Nov 5, 2019
Anticipated Primary Completion Date :
Nov 20, 2021
Anticipated Study Completion Date :
Jan 10, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Upper extremity surgery under general anaesthesia

Fentanyl 2 mcg/kg iv, propofol 2 mg/kg iv induction, 1MAC sevoflurane maintenance

Procedure: Upper extremity surgery under general anaesthesia
Forearm, wrist and hand surgery after fentanyl and propofol induction of anaesthesia, with sevoflurane maintenance

Active Comparator: Upper extremity surgery under regional anaesthesia

Bupivacaine brachial plexus block 0.4 ml/kg of 0.33% solution

Procedure: Upper extremity surgery under regional anaesthesia
Forearm, wrist and hand surgery under brachial plexus block with 0.4 ml/kg of 0.33% bupivacaine solution Other Names: Marcaine 5 mg/ml Astra Zeneca OGYI-T 6496/14

Outcome Measures

Primary Outcome Measures

  1. Somatostatin concentration in plasma [0-6 hours after surgery]

    Plasma concentrations of somatostatin straight after and 6 hours after surgery.

Secondary Outcome Measures

  1. Endocannabinoid concentrations in plasma [0-6 hours]

    Plasma concentrations of endocannabinoids straight after and 6 hours after surgery.

  2. Corticosteroid concentrations in plasma [0-6 hours]

    Plasma concentrations of corticosteroids straight after and 6 hours after surgery.

Other Outcome Measures

  1. Postoperative pain intensity: verbal numeric rate scale [0-24 hours]

    Postoperative pain intensity in a 0-10 point verbal numeric rate scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • upper extremity fracture

  • surgery of hand/forearm or upper arm

  • unpremedicated patients

  • scheduled for elective or emergency trauma

Exclusion Criteria:
  • psycho-mental conditions interfering with consent or assessment

  • the patient refused to participate

  • preexisting chronic pain condition

  • daily analgesic or sedative or steroid consumption

  • sedative or analgesic premedication

  • pre-existing neuro-endocrine disorders

  • antecedent cancer

  • advanced liver or kidney disease.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pécs, Medical School Pécs Baranya Hungary 7632

Sponsors and Collaborators

  • University of Pecs

Investigators

  • Study Chair: Robert G Almasi, PhD.Habil., University of Pecs, Medical School, Clinical Centre, Pain Medicine Dept.of Anesth Int Care
  • Principal Investigator: Zsofia Kriszta, MD., University of Pecs, Medical School, Clinical Centre, Dept.of Anesth Int Care

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Pecs
ClinicalTrials.gov Identifier:
NCT04040738
Other Study ID Numbers:
  • 7726
First Posted:
Aug 1, 2019
Last Update Posted:
Nov 5, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 5, 2021